Search by Drug Name or NDC
NDC 00456-2212-30 Fetzima 120 mg/1 Details
Fetzima 120 mg/1
Fetzima is a ORAL CAPSULE, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Allergan, Inc.. The primary component is LEVOMILNACIPRAN HYDROCHLORIDE.
MedlinePlus Drug Summary
Levomilnacipran is used to treat depression. Levomilnacipran is in a class of medications called selective serotonin and norepinephrine reuptake inhibitors (SNRIs). It works by increasing the amount of serotonin and norepinephrine, natural substances in the brain that helps maintain mental balance.
Related Packages: 00456-2212-30Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Levomilnacipran
Product Information
| NDC | 00456-2212 |
|---|---|
| Product ID | 0456-2212_7b3b300a-81f4-4b72-ad88-71e95d182456 |
| Associated GPIs | 58180050107080 |
| GCN Sequence Number | 071498 |
| GCN Sequence Number Description | levomilnacipran HCl CAP SA 24H 120 MG ORAL |
| HIC3 | H7C |
| HIC3 Description | SEROTONIN-NOREPINEPHRINE REUPTAKE-INHIB (SNRIS) |
| GCN | 35334 |
| HICL Sequence Number | 040632 |
| HICL Sequence Number Description | LEVOMILNACIPRAN HCL |
| Brand/Generic | Brand |
| Proprietary Name | Fetzima |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | LEVOMILNACIPRAN HYDROCHLORIDE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE, EXTENDED RELEASE |
| Route | ORAL |
| Active Ingredient Strength | 120 |
| Active Ingredient Units | mg/1 |
| Substance Name | LEVOMILNACIPRAN HYDROCHLORIDE |
| Labeler Name | Allergan, Inc. |
| Pharmaceutical Class | Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA204168 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00456-2212-30 (00456221230)
| NDC Package Code | 0456-2212-30 |
|---|---|
| Billing NDC | 00456221230 |
| Package | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0456-2212-30) |
| Marketing Start Date | 2013-07-25 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 16.0214 |
| Pricing Unit | EA |
| Effective Date | 2024-01-02 |
| NDC Description | FETZIMA ER 120 MG CAPSULE |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4 |
| Classification for Rate Setting | B |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis